Skip to content
Screener

Celcuity CELC Retained Earnings

Retained Earnings at other companies

Eli Lilly logo
Eli LillyLLY
$31.89B+83.5%
Gilead Sciences logo
Gilead SciencesGILD
$2.2B-80.6%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$3.99B-22.1%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-$2.17B-15.2%
Immunome logo
ImmunomeIMNM
-$782M-40.3%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
-$728.01M-22.8%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.55B+150%
Enterprise value$4.54B+142%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The source filing: Celcuity’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 5:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001493152-26-023180
Line itemMarch 31, 2026December 31, 2025
Commitments and contingencies (Note 6)--
Stockholders’ equity:
Preferred stock, $0.001 par value; 2,500,000 shares authorized as of March 31, 2026, and December 31, 2025; 0 shares issued and outstanding as of March 31, 2026, and December 31, 2025
Common stock, $0.001 par value; 95,000,000 shares authorized as of March 31, 2026, and December 31, 2025; 48,347,390 and 48,244,960 shares issued and outstanding as of March 31, 2026, and December 31, 2025, respectively4848
Additional paid-in capital555,215549,404
Accumulated deficit(501,738)(448,897)
Total stockholders’ equity53,525100,555
Total liabilities and stockholders’ equity$410,164$466,558

Item 1. Financial Statements (unaudited) ITEM

FAQ

What is Celcuity's retained earnings?
Celcuity (CELC) reported retained earnings of -$501.74M in Q1 2026.
How has Celcuity's retained earnings changed year-over-year?
Celcuity's retained earnings decreased by 62.5% year-over-year, from -$308.85M to -$501.74M.
What is the long-term trend for Celcuity's retained earnings?
Over 5 years (2020 to 2025), Celcuity's retained earnings has grown at a 76.3% compound annual growth rate (CAGR), from -$26.32M to -$448.9M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.

Ask your AI about Celcuity's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude